跳至主要内容
临床试验/NCT02998827
NCT02998827Unknown不适用

Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD Patients

Sixth Affiliated Hospital, Sun Yat-sen University0 个研究点目标入组 90 人开始时间: 2016年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
90
主要终点
difference AMH between thalidomide group and other treatment group

研究概览

简要总结

The effectiveness of thalidomide in treating inflammatory bowel disease has been widely recognized. Meanwhile, many serious adverse drug reactions were notified, but no reports on ovarian reserve function.Therefore, this study was to investigate the influence of thalidomide on function of ovarian reserve.

详细描述

It will be divided two groups of patients according to the treatment itself . One group was treated by thalidomide, the other was other treatment excluding. It will detect the function of ovarian reserve before and after treatment in both two groups, to investigate the influence of thalidomide on function of ovarian reserve.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Age 18-50 years old Diagnosis of patients with CD

排除标准

  • Pregnancy or lactation Period of women have fertility program during the study Treatment not foot eight weeks after last IFX Central or peripheral nerve disease Abnormal in liver and renal function Heart function failure Malignant tumor Active tuberculosis

研究组 & 干预措施

thalidomide

Experimental

use thalidomide tablet by mouth, every night for at least 6 months

干预措施: Thalidomide (Drug)

other treatment

Active Comparator

the treatment include infliximab, azathioprine or enteral nutrition at least 6 months

干预措施: infliximab, azathioprine (Drug)

other treatment

Active Comparator

the treatment include infliximab, azathioprine or enteral nutrition at least 6 months

干预措施: enteral nutrition (Other)

结局指标

主要结局

difference AMH between thalidomide group and other treatment group

时间窗: 1 year

Anti-mullerian hormone(AMH), as an important index to monitor the function of ovarian reserve, is majorly secreted by preantral follicles and antral follicles without fluctuation during menstrual cycle, not affected by hormone, and its change is earlier than sex hormone.

difference AFC between thalidomide group and other treatment group

时间窗: 1 year

The foundational follicles at 5- 10 mm of both ovaries were determined and the sum of antral follicles of both sides of ovaries was as antral follicles communicate (AFC)

difference FSH between thalidomide group and other treatment group

时间窗: 1 year

Follicle stimulating hormone,a kind of hormone

difference E2 between thalidomide group and other treatment group

时间窗: 1 year

estradiol,a kind of hormone

次要结局

未报告次要终点

研究者

发起方
Sixth Affiliated Hospital, Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

pengxiang

Principal Investigator

Sixth Affiliated Hospital, Sun Yat-sen University

相似试验